A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients

被引:19
作者
Abdulla, Alan [1 ]
Ewoldt, Tim M. J. [2 ]
Purmer, Ilse M. [3 ]
Muller, Anouk E. [4 ,5 ]
Gommers, Diederik [2 ]
Endeman, Henrik [2 ]
Koch, Birgit C. P. [1 ]
机构
[1] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands
[2] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands
[3] Haga Hosp, Dept Intens Care, The Hague, Netherlands
[4] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
[5] Haaglanden Med Ctr, Dept Med Microbiol, The Hague, Netherlands
关键词
Β -lactam antibiotics; critically ill; predictors; risk factors; target attainment; therapeutic drug monitoring; AUGMENTED RENAL CLEARANCE; INTENSIVE-CARE-UNIT; PIPERACILLIN-TAZOBACTAM; CONTINUOUS-INFUSION; SEVERE SEPSIS; PHARMACOKINETICS; PHARMACODYNAMICS; MEROPENEM; CEFEPIME; THERAPY;
D O I
10.1080/17425255.2021.1879049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction : Emerging studies suggest that antibiotic pharmacokinetics (PK) are difficult to predict in critically ill patients. The high intra- and inter-patient PK variability makes it challenging to accurately predict the appropriate dosage required for a given patient. Identifying patients at risk could help clinicians to consider more individualized dosing regimens and perform therapeutic drug monitoring. We provide an overview of relevant predictors associated with target (non-)attainment of beta-lactam antibiotics in critically ill patients. Areas covered : This narrative review summarizes patient and clinical characteristics that can help to predict the attainment of target serum concentrations and to provide guidance on antimicrobial dose optimization. Literature was searched using Embase and Medline database, focusing on beta-lactam antibiotics in critically ill patients. Expert opinion : Adequate concentration attainment can be anticipated in critically ill patients prior to initiating empiric beta-lactam antibiotic therapy based on readily available demographic and clinical factors. Male gender, younger age, and augmented renal clearance were the most significant predictors for target non-attainment and should be considered in further investigations to develop dosing algorithms for optimal beta-lactam therapy.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 72 条
[1]   Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# [J].
Abdul-Aziz, Mohd H. ;
Alffenaar, Jan-Willem C. ;
Bassetti, Matteo ;
Bracht, Hendrik ;
Dimopoulos, George ;
Marriott, Deborah ;
Neely, Michael N. ;
Paiva, Jose-Artur ;
Pea, Federico ;
Sjovall, Fredrik ;
Timsit, Jean F. ;
Udy, Andrew A. ;
Wicha, Sebastian G. ;
Zeitlinger, Markus ;
De Waele, Jan J. ;
Roberts, Jason A. .
INTENSIVE CARE MEDICINE, 2020, 46 (06) :1127-1153
[2]   Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development [J].
Abdul-Aziz, Mohd H. ;
Lipman, Jeffrey ;
Mouton, Johan W. ;
Hope, William W. ;
Roberts, Jason A. .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) :136-153
[3]   The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial [J].
Abdulla, A. ;
Ewoldt, T. M. J. ;
Hunfeld, N. G. M. ;
Muller, A. E. ;
Rietdijk, W. J. R. ;
Polinder, S. ;
van Gelder, T. ;
Endeman, H. ;
Koch, B. C. P. .
BMC INFECTIOUS DISEASES, 2020, 20 (01)
[4]   Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT) [J].
Abdulla, Alan ;
Dijkstra, Annemieke ;
Hunfeld, Nicole G. M. ;
Endeman, Henrik ;
Bahmany, Soma ;
Ewoldt, Tim M. J. ;
Muller, Anouk E. ;
van Gelder, Teun ;
Gommers, Diederik ;
Koch, Birgit C. P. .
CRITICAL CARE, 2020, 24 (01)
[5]   Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia [J].
Aitken, Samuel L. ;
Altshuler, Jerry ;
Guervil, David J. ;
Hirsch, Elizabeth B. ;
Ostrosky-Zeichner, Luis L. ;
Ericsson, Charles D. ;
Tam, Vincent H. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (05) :541-544
[6]   Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients [J].
Akers, Kevin S. ;
Niece, Krista L. ;
Chung, Kevin K. ;
Cannon, Jeremy W. ;
Cota, Jason M. ;
Murray, Clinton K. .
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 :S163-S170
[7]   Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review [J].
Alobaid, Abdulaziz S. ;
Hites, Maya ;
Lipman, Jeffrey ;
Taccone, Fabio Silvio ;
Roberts, Jason A. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 47 (04) :259-268
[8]   What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients? [J].
Alobaid, Abdulaziz S. ;
Brinkmann, Alexander ;
Frey, Otto R. ;
Roehr, Anka C. ;
Luque, Sonia ;
Grau, Santiago ;
Wong, Gloria ;
Abdul-Aziz, Mohd-Hafiz ;
Roberts, Michael S. ;
Lipman, Jeffrey ;
Roberts, Jason A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) :696-702
[9]   Prevalence and Risk Factors for Augmented Renal Clearance in a Population of Critically Ill Patients [J].
Baptista, Joao Pedro ;
Martins, Paulo Jorge ;
Marques, Margarida ;
Pimentel, Jorge Manuel .
JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (10) :1044-1052
[10]   Augmented renal clearance in septic patients and implications for vancomycin optimisation [J].
Baptista, Joao Pedro ;
Sousa, Eduardo ;
Martins, Paulo J. ;
Pimentel, Jorge M. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (05) :420-423